Loading Nifty 50, Nifty Bank, and Sensex…
Bal Pharma Limited
BALPHARMA · Corporate filings
NSE
Bal Pharma Limited
BALPHARMA · NSE · Healthcare
₹88.10
4.99%
As of 12 Nov 2026
Bal Pharma Limited (BALPHARMA) is listed on NSE in the Healthcare sector. It last traded at ₹88.10, up 4.99% on the session. Its 52-week range is ₹60.00 to ₹124.60.
Research output is rule-based and informational only. It is not investment advice.
Analytics for BALPHARMA are not available yet. Technicals, fundamentals, peer ranking
and risk notes appear here once this listing's daily history and annual filings are synced.
Financial Charts & Report
Stock market charts for Bal Pharma Limited quarterly results: revenue, profit, margins, growth, and filing-derived operating metrics.
Loading financial charts...
Results Change Summary quarter-on-quarter and year-on-year filing evidence
Generate an evidence-linked summary of revenue, margin, profit, debt, cash and operating cash flow changes.
Financial Results figures in ₹ crore, except EPS/%
Loading…
Relative Returns stock, sector, and exchange benchmarks
Loading…
CAN SLIM William O'Neil's growth-stock criteria
Loading…
Latest Shareholding Pattern promoter, FII, DII, public and institution trend
Corporate Governance SEBI integrated governance filing
Loading governance disclosure...
Announcements
Announcement
Announcement
Announcement
Announcement
Announcement
Surveillance
Price band change (next trade date)
Surveillance
Price band change (next trade date)
Announcement
Governance
Insider trading
Announcement
Announcement
Announcement
News
Loading…
Corporate Actions dividends, bonuses, splits, buybacks, rights
Full history
Dividend
Dividend - Rs 1.20 Per Share Dividend - Rs 1.20 Per Share
Ex-date: 17 Sep 2026
Dividend
Dividend - Rs 1.20 Per Share Dividend - Rs 1.20 Per Share
Ex-date: 18 Sep 2025
Dividend
Annual General Me0etingdividend - Rs 1.2 Per Share Annual General Me0etingdividend - Rs 1.2 Per Share
Ex-date: 17 Sep 2024
Dividend
Annual General Meeting/Dividend - Re 1 Per Share Annual General Meeting/Dividend - Re 1 Per Share
Ex-date: 18 Sep 2023
Dividend
Annual General Meetingdividend - Re 1 Per Share Annual General Meetingdividend - Re 1 Per Share
Ex-date: 13 Sep 2022
Dividend
Annual General Meeting/Dividend - Re 1 Per Share Annual General Meeting/Dividend - Re 1 Per Share
Ex-date: 16 Sep 2021
Other
Annual General Meeting Annual General Meeting
Ex-date: 17 Sep 2020
Dividend
Annual General Meeting/Dividend - Re 1 Per Share Annual General Meeting/Dividend - Re 1 Per Share
Ex-date: 17 Sep 2019
Dividend
Annual General Meeting/Dividend Re 1 Per Share Annual General Meeting/Dividend Re 1 Per Share
Ex-date: 14 Sep 2018
Dividend
Annual General Meeting/Dividend - Re 1/- Per Share Annual General Meeting/Dividend - Re 1/- Per Share
Ex-date: 14 Sep 2017
Dividend
Annual General Meeting/Dividend Re 1/- Per Share Annual General Meeting/Dividend Re 1/- Per Share
Ex-date: 15 Sep 2016
Dividend
Annual General Meeting/ Dividend - Re 1/- Per Share Annual General Meeting/ Dividend - Re 1/- Per Share
Ex-date: 15 Sep 2015
Dividend
Annual General Meeting / Dividend - Re 1/- Per Share Annual General Meeting / Dividend - Re 1/- Per Share
Ex-date: 12 Sep 2014
Dividend
Annual General Meeting / Dividend - Re 0.75/- Per Share Annual General Meeting / Dividend - Re 0.75/- Per Share
Ex-date: 12 Sep 2013
Other
Annual General Meeting Annual General Meeting
Ex-date: 17 Sep 2012
Other
Annual General Meeting Annual General Meeting
Ex-date: 19 Sep 2011
Other
Annual General Meeting Annual General Meeting
Ex-date: 23 Sep 2010
Dividend
Dividend-Re.0.75 Pr Share Dividend-Re.0.75 Pr Share
Ex-date: 17 Sep 2009
Dividend
Agm/Dividend - 10% Agm/Dividend - 10%
Ex-date: 09 Sep 2008
Dividend
Agm/Dividend-7.5% Agm/Dividend-7.5%
Ex-date: 07 Sep 2007
Dividend
Agm/Dividend-7.5% Agm/Dividend-7.5%
Ex-date: 07 Sep 2006
Board Meetings
11 Nov 2026
Bal Pharma Limited has informed the Exchange regarding Outcome of Board Meeting held on November 11, 2026.As intimated vide our letter dated November 03, 2026, Board of directors of the Company met on Wednesday, November 11, 2026 inter alia transacted the following business.1. Considered and approved the unaudited Financial Results (Standalone and Consolidated) of the Company for Second quarter and Half year ended on 30th September, 2026. copy of the approved financial results together with the limited review report issued by the statutory auditors of the Company with unmodified opinion is enclosed. 2. Statement of Utilization of issue proceeds raised through Preferential Issue of Warrants and Statement of Material Deviation under Regulation 32(1) of the SEBI Listing Regulations Statement confirming that there is no deviation or variation in the utilization of these proceeds for the quarter ended September 30, 2026, is enclosed
11 Nov 2026
Bal Pharma Limited has submitted to the Exchange, the financial results for the period ended September 30, 2026.
12 Aug 2026
Bal Pharma Limited has informed the Exchange regarding Outcome of Board Meeting held on August 12, 2026.1. Considered and approved the unaudited Financial Results (Standalone and Consolidated) of the Company quarter ended on 30th June, 20262. Approved the change in designation of Mr. Ravindra Kumar Kothari (DIN: 03418320) from Non-Executive Director to Whole-Time Director3. Approved the change in designation of Mr. Virupakshaya Himesh (DIN: 08554422) from Whole-Time Director to Non-Executive Director4. Approved the proposal to make investment in the proposed Joint Venture entity to be incorporated in the Republic of the Philippines 5. approved the allotment of 10,00,000 (Ten Lakhs) Warrants to Mr. Shailesh Siroya, Promoter of the Company, on preferential basis
12 Aug 2026
Bal Pharma Limited has submitted to the Exchange, the financial results for the period ended Jun 30, 2026 and other Matters as outcome of Board Meeting
27 May 2026
Bal Pharma Limited has submitted to the Exchange, the financial results for the period ended March 31, 2026.
27 May 2026
Bal Pharma Limited has submitted to the Exchange, the financial results for the period ended March 31, 2026.
11 Feb 2026
Bal Pharma Limited has submitted to the Exchange, the financial results for the period ended December 31, 2025.
12 Nov 2025
Bal Pharma Limited has submitted to the Exchange, the financial results for the period ended September 30, 2025.